We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$274M
AUM Growth
-$6.67M
Cap. Flow
-$848K
Cap. Flow %
-0.31%
Top 10 Hldgs %
29.37%
Holding
164
New
33
Increased
27
Reduced
41
Closed
27

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$4.22M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$4.16M
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$4.05M
4
CRM icon
Salesforce
CRM
+$2.28M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.1M

Top Sells

Rank Stock Value
1
SP
SP Plus Corporation
SP
+$4.12M
2
OFIX icon
Orthofix Medical
OFIX
+$2.44M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$2.31M
4
IMCR icon
Immunocore
IMCR
+$2.26M
5
NUVL
Nuvalent
NUVL
+$2.23M

Sector Composition

Rank Sector Weight
1 Healthcare 43.71%
2 Technology 17%
3 Consumer Discretionary 6.54%
4 Energy 4.11%
5 Consumer Staples 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBC icon
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$33.4M 12.19%
1,436,136
– –
INSM icon
2
Insmed
INSM
$22.7B
$8.49M 3.1%
126,780
– –
MRUS
3
DELISTED
Merus
MRUS
$6.91M 2.52%
116,718
-4,962
-4% -$240K
CRM icon
4
Salesforce
CRM
$142B
$5.45M 1.99%
21,185
+8,506
+67% +$2.28M
AXSM icon
5
Axsome Therapeutics
AXSM
$12.3B
$5.01M 1.83%
62,192
+13,665
+28% +$1.01M
HCP
6
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$4.39M 1.6%
+130,200
New +$4.05M
HES
7
DELISTED
Hess
HES
$4.26M 1.56%
28,900
– –
CTLT
8
DELISTED
CATALENT, INC.
CTLT
$4.25M 1.55%
+75,600
New +$4.22M
JNPR
9
DELISTED
Juniper Networks
JNPR
$4.18M 1.53%
114,700
– –
ANSS
10
DELISTED
Ansys
ANSS
$4.12M 1.5%
12,800
– –
MSFT icon
11
Microsoft
MSFT
$2.89T
$4.09M 1.5%
9,158
-3,100
-25% -$1.31M
ETRN
12
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$4.02M 1.47%
+310,000
New +$4.16M
CERE
13
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$3.97M 1.45%
97,200
– –
ACI icon
14
Albertsons Companies
ACI
$5.57B
$3.73M 1.36%
188,753
– –
AMED
15
DELISTED
Amedisys
AMED
$3.6M 1.32%
39,250
– –
AMZN icon
16
Amazon
AMZN
$2.49T
$3.48M 1.27%
17,993
-2,100
-10% -$386K
INTU icon
17
Intuit
INTU
$83.1B
$3.2M 1.17%
4,863
+1,900
+64% +$1.18M
APGE icon
18
Apogee Therapeutics
APGE
$10.2B
$3.11M 1.13%
78,942
-40,461
-34% -$1.96M
BKNG icon
19
Booking.com
BKNG
$145B
$3M 1.1%
18,925
– –
CART icon
20
Maplebear
CART
$10.4B
$2.99M 1.09%
92,988
+30,588
+49% +$1.05M
ARGX icon
21
argenx
ARGX
$55.6B
$2.84M 1.04%
6,604
-141
-2% -$54K
XENE icon
22
Xenon Pharmaceuticals
XENE
$6.36B
$2.84M 1.04%
72,715
– –
ACLX
23
DELISTED
Arcellx
ACLX
$2.82M 1.03%
51,040
-21,190
-29% -$1.15M
XOMA
24
DELISTED
Xoma
XOMA
$2.82M 1.03%
118,899
– –
INDV icon
25
Indivior Pharmaceuticals
INDV
$4.73B
$2.8M 1.02%
178,836
– –
1
2 3 4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return

HighVista Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, HighVista Strategies held 164 positions worth $274M, down 2.4% from $280M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

HighVista Strategies's Q2 2024 filing shows 33 new, 27 increased, 41 reduced and 27 closed positions. Its largest new stake was CATALENT, INC.: 75,600 shares worth $4.25M. The largest sale was SP Plus Corporation, an estimated $4.12M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

  • HighVista Strategies's largest Q2 2024 buy was CATALENT, INC.: 75,600 shares worth $4.25M.
  • HighVista Strategies added most to Salesforce in Q2 2024, an estimated $2.28M increase.
  • HighVista Strategies's biggest Q2 2024 reduction was IDEAYA Biosciences, cutting an estimated $2.31M.
  • HighVista Strategies fully exited SP Plus Corporation in Q2 2024, selling an estimated $4.12M.
  • HighVista Strategies's ten largest holdings make up 29% of its $274M portfolio in Q2 2024.
  • HighVista Strategies opened 33 new positions and closed 27 in Q2 2024.
  • HighVista Strategies's portfolio value fell 2.4% quarter-over-quarter to $274M.

Based on HighVista Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.